GIMIGELA Trademark

Trademark Overview


On Tuesday, May 9, 2023, a trademark application was filed for GIMIGELA with the United States Patent and Trademark Office. The USPTO has given the GIMIGELA trademark a serial number of 97928201. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Structure Therapeutics USA Inc.. The GIMIGELA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for use in the treatment of metabolic, endocrine, diabetes and obesity-related diseases and disorders

Medical and scientific research and development in the fields of metabolic, endocrine, diabetes and obesity-related diseases and disorders and providing medical and scientific research information services
gimigela

General Information


Serial Number97928201
Word MarkGIMIGELA
Filing DateTuesday, May 9, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for use in the treatment of metabolic, endocrine, diabetes and obesity-related diseases and disorders
Goods and ServicesMedical and scientific research and development in the fields of metabolic, endocrine, diabetes and obesity-related diseases and disorders and providing medical and scientific research information services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameStructure Therapeutics USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameStructure Therapeutics USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Friday, May 12, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 7, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, November 7, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, February 1, 2024ASSIGNED TO EXAMINER
Monday, February 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 25, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 1 GRANTED
Friday, September 20, 2024SOU EXTENSION 1 FILED